Company Filing History:
2 out of 964 
2 out of 812 
2 out of 16 Years Active: 2019-2021
Title: Revital Shemer: Pioneering Innovator in Kidney Disease Research
Introduction
Revital Shemer, based in Haifa, Israel, is a prominent inventor known for her significant contributions to the field of nephrology. With two patents to her name, Shemer focuses on innovative methods and kits for determining predispositions to develop kidney diseases. Her work is crucial in advancing the understanding of genetic factors related to kidney health.
Latest Patents
Revital's latest patents revolve around the development of methods and kits aimed at identifying predispositions to kidney diseases. These inventions involve detecting at least one APOL1 polypeptide variant characterized by heightened trypanolytic activity compared to the wild type APOL1 polypeptide. The identification can be facilitated through analyzing a sample from the subject to recognize specific nucleotide mutations in the APOL1 genomic sequence. The presence of such variants can indicate an increased predisposition to developing kidney disease, illustrating the potential for early diagnosis and intervention in at-risk individuals.
Career Highlights
Throughout her career, Revital Shemer has contributed to leading institutions, notably the Technion Research & Development Foundation and Ramot at Tel-Aviv University. Her role in these institutions has allowed her to work on groundbreaking research and development in the medical field, particularly focusing on kidney health and disease susceptibility.
Collaborations
Revital has collaborated with notable figures in her field, including Karl L. Skorecki and Shay Tzur. These collaborations have enhanced her research approach and expanded the impact of her innovations on the medical community, promoting advancements in genetic research and patient care.
Conclusion
Revital Shemer exemplifies the spirit of innovation in the field of kidney disease research. Her patents not only contribute to scientific knowledge but also hold the potential to significantly improve patient outcomes by facilitating early detection and treatment. With a strong career foundation and collaborative network, Shemer continues to be a vital contributor to advancements in nephrology.